EGFR and posterior cortical atrophy: Dual inhibition of EGFR and HER2 poses as a promising prospect in terms of PCa therapy (Ahmad et al. 2011; Chen et al. 2011; Day et al. 2017; Sridhar et al. 2010), however to date, trials have been unsuccessful.